Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for retinal inflammatory conditions. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. more
Time Frame | KOD | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.13% | -2.12% | -3% |
1-Month Return | 49.4% | -3.42% | -0.73% |
3-Month Return | 227.65% | -11.13% | 2.87% |
6-Month Return | 243.25% | -5.74% | 7.17% |
1-Year Return | 210.04% | 3.97% | 25.31% |
3-Year Return | -90.24% | 1.05% | 28.38% |
5-Year Return | -87.1% | 34.37% | 81.89% |
10-Year Return | -14.86% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 911.00K | 4.21M | 8.71M | 11.00M | 25.95M | [{"date":"2019-12-31","value":3.51,"profit":true},{"date":"2020-12-31","value":16.22,"profit":true},{"date":"2021-12-31","value":33.57,"profit":true},{"date":"2022-12-31","value":42.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (911.00K) | (4.21M) | (8.71M) | (11.00M) | (25.95M) | [{"date":"2019-12-31","value":-91100000,"profit":false},{"date":"2020-12-31","value":-420800000,"profit":false},{"date":"2021-12-31","value":-871100000,"profit":false},{"date":"2022-12-31","value":-1100100000,"profit":false},{"date":"2023-12-31","value":-2594700000,"profit":false}] |
Gross Margin | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}] |
Operating Expenses | 49.19M | 136.01M | 267.05M | 341.38M | 277.32M | [{"date":"2019-12-31","value":14.41,"profit":true},{"date":"2020-12-31","value":39.84,"profit":true},{"date":"2021-12-31","value":78.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.24,"profit":true}] |
Operating Income | (49.19M) | (136.01M) | (267.05M) | (341.38M) | (277.32M) | [{"date":"2019-12-31","value":-4919000000,"profit":false},{"date":"2020-12-31","value":-13600700000,"profit":false},{"date":"2021-12-31","value":-26705100000,"profit":false},{"date":"2022-12-31","value":-34137900000,"profit":false},{"date":"2023-12-31","value":-27732100000,"profit":false}] |
Total Non-Operating Income/Expense | 3.38M | 5.79M | 337.00K | 14.61M | 33.55M | [{"date":"2019-12-31","value":10.09,"profit":true},{"date":"2020-12-31","value":17.25,"profit":true},{"date":"2021-12-31","value":1,"profit":true},{"date":"2022-12-31","value":43.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (47.37M) | (133.10M) | (266.99M) | (333.82M) | (260.49M) | [{"date":"2019-12-31","value":-4736500000,"profit":false},{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false}] |
Income Taxes | (638.00K) | 2.73M | (153.56K) | 7.35M | - | [{"date":"2019-12-31","value":-8.69,"profit":false},{"date":"2020-12-31","value":37.16,"profit":true},{"date":"2021-12-31","value":-2.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (46.73M) | (135.83M) | (266.84M) | (341.17M) | - | [{"date":"2019-12-31","value":-4672700000,"profit":false},{"date":"2020-12-31","value":-13582570300,"profit":false},{"date":"2021-12-31","value":-26683644200,"profit":false},{"date":"2022-12-31","value":-34116851500,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (47.37M) | (133.10M) | (266.99M) | (333.82M) | (260.49M) | [{"date":"2019-12-31","value":-4736500000,"profit":false},{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (46.73M) | (133.10M) | (266.99M) | (333.82M) | (260.49M) | [{"date":"2019-12-31","value":-4672700000,"profit":false},{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false}] |
EPS (Diluted) | (1.25) | (2.89) | (5.15) | (6.39) | (4.96) | [{"date":"2019-12-31","value":-125,"profit":false},{"date":"2020-12-31","value":-289,"profit":false},{"date":"2021-12-31","value":-515,"profit":false},{"date":"2022-12-31","value":-639,"profit":false},{"date":"2023-12-31","value":-496,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
KOD | |
---|---|
Cash Ratio | 8.22 |
Current Ratio | 8.42 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
KOD | |
---|---|
ROA (LTM) | -26.72% |
ROE (LTM) | -71.50% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
KOD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.50 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.50 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
KOD | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 2.46 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Kodiak Sciences Inc (KOD) share price today is $8.65
Yes, Indians can buy shares of Kodiak Sciences Inc (KOD) on Vested. To buy Kodiak Sciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KOD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Kodiak Sciences Inc (KOD) via the Vested app. You can start investing in Kodiak Sciences Inc (KOD) with a minimum investment of $1.
You can invest in shares of Kodiak Sciences Inc (KOD) via Vested in three simple steps:
The 52-week high price of Kodiak Sciences Inc (KOD) is $11.6. The 52-week low price of Kodiak Sciences Inc (KOD) is $2.19.
The price-to-earnings (P/E) ratio of Kodiak Sciences Inc (KOD) is
The price-to-book (P/B) ratio of Kodiak Sciences Inc (KOD) is 2.46
The dividend yield of Kodiak Sciences Inc (KOD) is 0.00%
The market capitalization of Kodiak Sciences Inc (KOD) is $456.77M
The stock symbol (or ticker) of Kodiak Sciences Inc is KOD